Clicca qui per leggere l’articolo “Phase 1 Lymfactin® Study: 24-month Efficacy and Safety Results of Combined Adenoviral VEGF-C and Lymph Node Transfer Treatment for Upper Extremity Lymphedema” pubblicato sul Journal of Plastic, Reconstructive & Aesthetic Surgeryad agosto 2022.
